Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast
Condition(s):Intraductal Carcinoma and Lobular Carcinoma in SituLast Updated:August 25, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Intraductal Carcinoma and Lobular Carcinoma in SituLast Updated:August 25, 2016Completed
Condition(s):Ductal Carcinoma in SituLast Updated:April 9, 2020Terminated
Condition(s):Ductal Carcinoma In SituLast Updated:May 15, 2019Completed
Condition(s):Ductal Carcinoma In SituLast Updated:October 2, 2008Unknown status
Condition(s):Ductal Carcinoma in Situ; Extensive Disease; MastectomyLast Updated:December 14, 2020Not yet recruiting
Condition(s):Ductal Carcinoma in SituLast Updated:February 28, 2017Completed
Condition(s):Ductal Breast Carcinoma in SituLast Updated:February 6, 2020Recruiting
Condition(s):Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)Last Updated:December 11, 2020Terminated
Condition(s):Breast Ductal Carcinoma in SituLast Updated:August 6, 2019Recruiting
Condition(s):Breast CancerLast Updated:April 14, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.